{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Test SSR - CE Articles-4

Activity Steps

1 Take Test
2 Activity

Description

Description To provide a comprehensive update on the actions and effects of ketamine in specific pain-control applications and on the etiology, risk factors, assessment, and management of gestational diabetes.

Purpose of Activity

To provide a comprehensive update on the actions and effects of ketamine in specific pain-control applications and on the etiology, risk factors, assessment, and management of gestational diabetes.

Learning Objectives

After completing this continuing education activity you will be able to:

  • describe the pharmacology, actions, and indications for ketamine, as well as outline its adverse effects.
  • discuss the etiology, incidence, and risks associated with gestational diabetes.
  • outline the current diagnostic protocols for gestational diabetes.

Learning Outcomes

Learning Outcomes To provide a comprehensive update on the actions and effects of ketamine in specific pain-control applications and on the etiology, risk factors, assessment, and management of gestational diabetes.

Disclosures

Disclosure Text To provide a comprehensive update on the actions and effects of ketamine in specific pain-control applications and on the etiology, risk factors, assessment, and management of gestational diabetes.

Price: $27.95

Credits:

  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.





Planner
Test Code: AJN050420211
Published: November 2023
Expires: 1/1/2025
Collections: Automation Collection Name 1153551 , Automation Collection Name 1202282 , CEC Collection for Test
Sources: AJN, American Journal of Nursing
Required Passing Score: 12/18 (66%)
Authors: Chris Pasero MS, RN, FAAN, Margo McCaffery MS, RN, FAAN
Categories: Drug Therapy
Specialties: Medical-Surgical